ContractClinical Study Agreement • January 29th, 2018
Contract Type FiledJanuary 29th, 2018AMENDMENT 1 TO CLINICAL STUDY AGREEMENT DODATEK č. 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ THIS AMENDMENT AGREEMENT (the“Amendment 1”) is entered into as of 19 April 2017 between inVentiv Health Clinical UK Limited with a place of business at Thames House, 17-19 Marlow Road, Maidenhead, Berkshire SL6 7AA United Kingdom (hereinafter “CRO”), and Krajská zdravotní, a.s., with a place of business at Sociální péče 3316/12A, 401 13 Ústí nad Labem, Czech Republic, Identification number: 25488627, Tax ID: CZ25488627, represented by , CEO. Study will be conducted at Department of Oncology in Krajská zdravotní, a.s. - Masarykova nemocnice Ústí nad Labem, o. z., V Podhájí 21, 401 13 Ústí nad Labem, Czech Republic (“Institution”). TENTO DODATEK KE SMLOUVĚ (dále jen„dodatek č. 1”) se uzavírá ke dni 19. dubna 2017 mezi inVentiv Health Clinical UK Limited, se sídlem na adrese Thames House, 17-19 Marlow Road, Maidenhead, Berkshire SL6 7AA Spojené království (dále jen „CRO“), a Krajská zdravotní, a.s.,